New Tool Developed by RAND Corp. Uses Air Travel Data to Predict COVID-19 Risk
A new tool developed by the RAND Corporation analyzes COVID-19 cases and air travel data to predict the spread of the coronavirus.
According to the non-profit think tank, by providing estimates of the number of infected passengers, the tool can help policymakers better respond to the public health threat.
In fact, RAND’s researchers say, the tool has already revealed valuable insights.
The tool, officially, the COVID-19 Air Traffic Visualization (CAT-V) tool, suggests that by late January, at least one or more infected passengers per day were likely flying from China to international destinations.
Around this time, they say, it is also likely that the number of cases in China was 37 times higher than reported by Beijing.
The tool also shows that the risk to Gulf Cooperation Council countries was greater from outside the region than from Iran, contradicting common narratives about how the virus was introduced.
The researchers — Russell Hanson, Christopher A. Mouton, Adam R. Grissom, and John P. Godges — say that combining this data makes it possible to visualize how coronavirus disease 2019 (COVID-19) infections and commercial air travel have interacted to export infection risk across the world.
“Given air travel data and reported infection rates, our tool can also be used to estimate future patterns of COVID-19 transmission. As a result, policymakers, analysts, and others can estimate the impact of travel-related policy interventions, such as restricting air travel from various countries,” the researchers say in a post on the RAND website.
The CAT-V tool offers a “heat map” feature and the ability to visualize the risk associated with individual air travel routes. The tool is currently an internal prototype model being refined for possible public release.
“We will continue to develop and use the CAT-V tool in new ways, and we will continue to release a stream of derivative findings on topics of interest to policymakers,” the researchers say.
In accordance with RAND’s quality assurance standards, the researchers note their analysis is based on the best available data. “However, COVID-19 is an evolving threat, and even the best available data being used by government agencies and research institutes have very significant limitations,” they say.
In The News
WASHINGTON — President Joe Biden said during a virtual meeting with essential workers on Wednesday that the administration plans to distribute millions of cloth face masks beginning early next month. According to a statement from the White House, the reusable, American-made masks will be available beginning in March... Read More
WASHINGTON (AP) — Johnson & Johnson's single-dose vaccine protects against COVID-19, according to an analysis by U.S. regulators Wednesday that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic. The Food and Drug Administration's scientists confirmed that overall the... Read More
WASHINGTON — The House Budget Committee approved reconciliations to President Joe Biden’s proposed $1.9 trillion novel coronavirus relief legislation Monday, setting in motion the bill’s final vote in the full House of Representatives expected to follow this week. If enacted, the legislation would provide $1,400 economic... Read More
WASHINGTON (AP) — Democratic leaders have a potent dynamic on their side as Congress preps for its first votes on the party's $1.9 trillion COVID-19 relief bill: Would any Democrat dare cast the vote that scuttles new President Joe Biden's leadoff initiative?Democrats' wafer-thin 10-vote House majority... Read More
The U.S. stood Sunday at the brink of a once-unthinkable tally: 500,000 people lost to the coronavirus.A year into the pandemic, the running total of lives lost was about 498,000 — roughly the population of Kansas City, Missouri, and just shy of the size of Atlanta.... Read More
NEW YORK -- A groundbreaking “Back-to-Normal Barometer” survey for the first time finds that only half of Americans say that they will receive a COVID-19 vaccine once it becomes available for them to receive it. Driving this lack of enthusiasm, 60% of people surveyed don’t believe... Read More